Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nahal Haddadi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|October 2, 2020
Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19Eileen M McGowan, Nahal Haddadi, Najah T Nassif, et al.
Oncotarget|April 19, 2017
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotargetDiana Hatoum, Nahal Haddadi, Yiguang Lin, et al.
Cold Spring Harbor Perspectives in Medicine|October 17, 2019
Toward Systems Pathology for PTEN DiagnosticsNahal Haddadi, Glena Travis, Najah T Nassif, et al.
International Journal of Molecular Sciences|September 5, 2017
"Dicing and Splicing" Sphingosine Kinase and Relevance to CancerNahal Haddadi, Yiguang Lin, Ann M Simpson, et al.
Molecular Cancer|February 20, 2018
PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapyNahal Haddadi, Yiguang Lin, Glena Travis, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2021
Studying the Oncosuppressive Functions of PTENP1 as a ceRNAGlena Travis, Nahal Haddadi, Ann M Simpson, et al.
Journal of Oncology|December 19, 2022
Expression Profile of Sphingosine Kinase 1 Isoforms in Human Cancer Tissues and Cells: Importance and Clinical Relevance of the Neglected 1b-IsoformHongjie Chen, Nahal Haddadi, Xiaofeng Zhu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|October 2, 2020
Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19Eileen M McGowan, Nahal Haddadi, Najah T Nassif, et al.
Oncotarget|April 19, 2017
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotargetDiana Hatoum, Nahal Haddadi, Yiguang Lin, et al.
Cold Spring Harbor Perspectives in Medicine|October 17, 2019
Toward Systems Pathology for PTEN DiagnosticsNahal Haddadi, Glena Travis, Najah T Nassif, et al.
International Journal of Molecular Sciences|September 5, 2017
"Dicing and Splicing" Sphingosine Kinase and Relevance to CancerNahal Haddadi, Yiguang Lin, Ann M Simpson, et al.
Molecular Cancer|February 20, 2018
PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapyNahal Haddadi, Yiguang Lin, Glena Travis, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2021
Studying the Oncosuppressive Functions of PTENP1 as a ceRNAGlena Travis, Nahal Haddadi, Ann M Simpson, et al.
Journal of Oncology|December 19, 2022
Expression Profile of Sphingosine Kinase 1 Isoforms in Human Cancer Tissues and Cells: Importance and Clinical Relevance of the Neglected 1b-IsoformHongjie Chen, Nahal Haddadi, Xiaofeng Zhu, et al.
Pageof 1